Q&A: What Do FDA’s Recent Medical App Approvals Mean For Industry?
Executive Summary
Marc Scheineson, a former US FDA associate commissioner who now heads Alston & Bird’s food and drug law practice, offered insight into the agency's latest moves in regulating medical apps and what industry should watch for.